Hello, everyone, and how are you today? We hope the weekend was relaxing and refreshing. Now, though, the time has come to resume that familiar routine of meetings and deadlines and more meetings. As always, there is much to do. For instance, we are preparing to host a panel at theDIA gathering next week. Meanwhile, though, we must tend to today. So please join us for a cup of stimulation as we dig in. Hope your day goes well and stay in touch...
Onyx Cancer Drug Risks Outweigh Benefit: FDA Staff (Bloomberg News)
Merck Loses Patent Ruling Against Apotex Over Nasonex (Bloomberg News)
Biotech Talent Flows Toward Boston (Boston Globe)
Piramal In Talks To Buy Cambridge Major Labs (Financial Express)
Valeant Buys Dental Specialist OraPharma (Pharma Times)
Mystery Sounds From A Merck Plant? No One Knows (The Reporter)
EDITOR'S NOTE: Please check this post for updates during the day